• Aibotics posted a net loss of $418,105 for the quarter ended March 31, 2026, narrowing from $591,397 a year earlier.
• General and administrative expense fell 32% to $359,463, driven mainly by lower product development expense and reduced legal and professional services.
• Revenue was nil, versus $2,183 a year earlier.
• Cash and cash equivalents rose to $288,858 at March 31, 2026, while working capital deficit widened to $4.72 million.
• Management flagged substantial doubt about going-concern ability within one year, citing a $4.72 million working capital deficit and continued losses.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aibotics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001096906-26-000922), on June 09, 2026, and is solely responsible for the information contained therein.